Papaverine Hydrochloride Injection and Trastuzumab and Hyaluronidase
Determining the interaction of Papaverine Hydrochloride Injection and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: papaverine
Brand name: Para-Time SR
Synonyms: Papaverine
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Papaverine Hydrochloride Injection-Trastuzumab Injection (Intravenous)
- Papaverine Hydrochloride Injection-Trastuzumab Intravenous
- Papaverine Hydrochloride Injection-Trastuzumab-anns
- Papaverine Hydrochloride Injection-Trastuzumab-dkst
- Papaverine Hydrochloride Injection-Trastuzumab-dkst Intravenous
- Papaverine Hydrochloride Injection-Trasylol
- Trastuzumab and Hyaluronidase-Papaverine Injection
- Trastuzumab and Hyaluronidase-Papaya
- Trastuzumab and Hyaluronidase-Papillomavirus (9-Valent) Vaccine (Human, Recombinant)
- Trastuzumab and Hyaluronidase-Papillomavirus (Types 16, 18) Vaccine (Human, Recombinant)
- Trastuzumab and Hyaluronidase-Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)
- Trastuzumab and Hyaluronidase-Para-Time S.R.